Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL394474 | 0.90 | CA2 (0.63) | CA2CA1MAPK1ACHEGAA | |
| Piperazine SCHEMBL11068926 | 0.84 | CA2 (0.53) | CA2CA1MAPK1ACHEGAA | |
| Ethylene Glycol SCHEMBL9625020 | 0.83 | CA2 (0.63) | CA2CA1MAPK1ACHEGAA | |
| SCHEMBL1428342 | 0.83 | CA2 (0.52) | CA2CA1MAPK1ACHEATM | |
| SCHEMBL9327517 | 0.82 | CA2 (0.61) | CA2CA1MAPK1ACHEGAA | |
| SCHEMBL154056 | 0.81 | CA2 (0.70) | CA2CA1MAPK1ACHEGAA | |
| SCHEMBL8985885 | 0.81 | CA2 (0.56) | CA2CA1MAPK1ACHEGAA | |
| SCHEMBL474747 | 0.81 | CA2 (0.56) | CA2CA1MAPK1ACHEGAA | |
| SCHEMBL17626978 | 0.81 | CA2 (0.56) | CA2CA1MAPK1ACHEGAA | |
| SCHEMBL9167701 | 0.81 | CA2 (0.56) | CA2CA1MAPK1ACHEGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530558-B2 | Plasticizers comprising poly(trimethylene ether) glycol esters | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-10 | — | — | US | claimed |
| EP-2274374-A1 | PLASTICIZERS COMPRISING POLY(TRIMETHYLENE ETHER) GLYCOL ESTERS | E. I. du Pont de Nemours and Company (US) | 2011-01-19 | — | — | EP | claimed |
| US-20090281220-A1 | PLASTICIZERS COMPRISING POLY(TRIMETHYLENE ETHER) GLYCOL ESTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-12 | — | — | US | claimed |
| WO-2009137443-A1 | PLASTICIZERS COMPRISING POLY(TRIMETHYLENE ETHER) GLYCOL ESTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-12 | — | — | WO | claimed |
| EP-2207521-B1 | DEODORANT COMPOSITIONS | DU PONT (US) | 2015-04-29 | — | — | EP | disclosed |
| EP-2838874-A1 | PROCESSES FOR PREPARING POLYTRIMETHYLENE ETHER GLYCOL ESTERS | E. I. Du Pont de Nemours and Company (US) | 2015-02-25 | — | — | EP | disclosed |
| US-20150051326-A1 | PLASTICIZERS COMPRISING POLY(TRIMETHYLENE ETHER) GLYCOL ESTERS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-02-19 | — | — | US | disclosed |
| US-8759559-B2 | Processes for preparing polytrimethylene ether glycol esters | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-06-24 | — | — | US | disclosed |
| WO-2013158388-A1 | PROCESSES FOR PREPARING POLYTRIMETHYLENE ETHER GLYCOL ESTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-24 | — | — | WO | disclosed |
| US-20130281723-A1 | PROCESSES FOR PREPARING POLYTRIMETHYLENE ETHER GLYCOL ESTERS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-24 | — | — | US | disclosed |
| US-8530558-B2 | Plasticizers comprising poly(trimethylene ether) glycol esters | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-10 | — | — | US | disclosed |
| US-8409596-B2 | Deodorant compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-04-02 | — | — | US | disclosed |
| US-20120107260-A1 | DEODORANT COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-05-03 | — | — | US | disclosed |
| US-8114423-B2 | Deodorant compositions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-14 | — | — | US | disclosed |
| EP-2274374-A1 | PLASTICIZERS COMPRISING POLY(TRIMETHYLENE ETHER) GLYCOL ESTERS | E. I. du Pont de Nemours and Company (US) | 2011-01-19 | — | — | EP | disclosed |
| EP-2207521-A2 | DEODORANT COMPOSITIONS | E. I. du Pont de Nemours and Company (US) | 2010-07-21 | — | — | EP | disclosed |
| US-20090281220-A1 | PLASTICIZERS COMPRISING POLY(TRIMETHYLENE ETHER) GLYCOL ESTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-12 | — | — | US | disclosed |
| WO-2009137443-A1 | PLASTICIZERS COMPRISING POLY(TRIMETHYLENE ETHER) GLYCOL ESTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-11-12 | — | — | WO | disclosed |
| WO-2009048445-A2 | DEODORANT COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-04-16 | — | — | WO | disclosed |
| US-20090092569-A1 | DEODORANT COMPOSITIONS | Covation Inc. | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130281723-A1 | PROCESSES FOR PREPARING POLYTRIMETHYLENE ETHER GLYCOL ESTERS | PGAM1, MCCC2, PHOSPHO1 | CA2 2095/4885CA1 279/4885MAPK1 2648/4885 |
| US-20090092569-A1 | DEODORANT COMPOSITIONS | DDT, PGD, HPD | CA2 3013/4885CA1 2191/4885MAPK1 2991/4885 |
| US-20120107260-A1 | DEODORANT COMPOSITIONS | DDT, PGD, HPD | CA2 2944/4885CA1 2291/4885MAPK1 3056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.